BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 31996583)

  • 1. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and Outcomes of Pathologic Upstaging of Clinical Stage I Rectal Cancers: An Exploratory Analysis.
    Lussiez A; Rivard SJ; Hollingsworth K; Abdel-Misih SRZ; Bauer PS; Hrebinko KA; Balch GC; Maguire LH
    Dis Colon Rectum; 2023 Apr; 66(4):543-548. PubMed ID: 35849821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential Lateral Lymphatic Metastasis Shows Similar Oncologic Outcomes to Upward Spread in Advanced Rectal Cancer After Preoperative Chemoradiotherapy.
    Kim HJ; Choi GS; Cho SH; Kang MK; Park JS; Park SY; Kang BW; Kim JG
    Dis Colon Rectum; 2024 Mar; 67(3):359-368. PubMed ID: 37962146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Propensity Score-Matched Analysis of the Impact of Neoadjuvant Radiation Therapy on the Outcomes of Stage II and III Mucinous Rectal Carcinoma.
    Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Wexner SD
    Dis Colon Rectum; 2024 May; 67(5):655-663. PubMed ID: 38231014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.
    Ke J; Jin C; Tang J; Cao H; He S; Ding P; Jiang X; Zhao H; Cao W; Meng X; Gao F; Lan P; Li R; Wu X
    Dis Colon Rectum; 2023 Dec; 66(12):e1195-e1206. PubMed ID: 37682775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database.
    Kamel MK; Shchatsko A; Keane CA; Serpa E; Al-Qudah G; Rahouma M; Nituica C; Blebea J; Marar O
    Dis Colon Rectum; 2023 Nov; 66(11):1435-1448. PubMed ID: 36876973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic Disparities in Anal Cancer: Effect on Treatment Delay and Survival.
    Nepal P; Zafar MH; Liu LC; Xu Z; Abdulhai MA; Perez-Tamayo AM; Chaudhry V; Mellgren AF; Gantt GA
    Dis Colon Rectum; 2024 Jun; 67(6):773-781. PubMed ID: 38411981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management.
    Feferman Y; Rosen RY; Gebran S; Yuval JB; Kerioui M; Gönen M; Wei IH; Widmar M; Nash GM; Weiser MR; Paty PB; Hajj C; Roth O'Brien DA; Romesser PB; Crane CH; Smith JJ; Garcia Aguilar J; Pappou EP
    Dis Colon Rectum; 2024 Apr; 67(4):496-504. PubMed ID: 38127627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
    Kyong Shin J; Ah Park Y; Wook Huh J; Hyeon Yun S; Cheol Kim H; Yong Lee W; Hyung Kim S; Yun Ha S; Cho YB
    Dis Colon Rectum; 2023 Aug; 66(8):e801-e808. PubMed ID: 35394982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease.
    Hajirawala LN; Yi Y; Herritt BC; Laurent ME; Klinger AL; Orangio GR; Davis KG; Barton JS
    Dis Colon Rectum; 2023 Aug; 66(8):1076-1084. PubMed ID: 35239528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Recurrence-Free Survival After TaTME: A Canadian Institutional Experience.
    Hershorn O; Ghuman A; Karimuddin AA; Raval MJ; Phang PT; Brown CJ
    Dis Colon Rectum; 2024 May; 67(5):664-673. PubMed ID: 38319633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Analysis of Local Recurrence and Survival After Transanal Abdominal Transanal Radical Proctosigmoidectomy for Low Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
    Marks JH; Reif de Paula T; Saidi H; Ikner TP; Schoonyoung H; Marks G; Keller DS
    Dis Colon Rectum; 2024 Mar; 67(3):377-386. PubMed ID: 38064243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateral Pelvic Nodal Management and Patterns of Failure in Patients Receiving Short-Course Radiation for Locally Advanced Rectal Cancer.
    Hassanzadeh C; Mirza K; Kalaghchi B; Fallahian F; Chin RI; Roy A; Stowe H; Low G; Pedersen K; Wise P; Glasgow S; Roach M; Henke L; Badiyan S; Mutch M; Kim H
    Dis Colon Rectum; 2024 Jan; 67(1):54-61. PubMed ID: 37787502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Their Whole Lives Are Going To Change": A Photo-Elicitation Study of Rectal Cancer Survivorship.
    Rivard SJ; Vitous CA; Bamdad MC; Varlamos C; Duby A; Suwanabol PA
    Dis Colon Rectum; 2022 Dec; 65(12):1456-1463. PubMed ID: 36382839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes Following Pelvic Exenteration for Locally Recurrent Rectal Cancer With and Without En Bloc Sacrectomy.
    Waller JH; van Kessel CS; Solomon MJ; Lee PJ; Austin KKS; Steffens D
    Dis Colon Rectum; 2024 Jun; 67(6):796-804. PubMed ID: 38408876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Value of Micropapillary Pattern in Colon Cancer and Its Role as a High-Risk Feature in Patients With Stage II Disease.
    Pyo DH; Kim SH; Shin JK; Park Y; Huh JW; Kim HC; Yun SH; Lee WY; Cho YB
    Dis Colon Rectum; 2023 Nov; 66(11):1462-1472. PubMed ID: 37339285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Implications of Lateral Lymph Nodes in Rectal Cancer: A Population-Based Cross-sectional Study With Standardized Radiological Evaluation After Dedicated Training.
    Sluckin TC; van Geffen EGM; Hazen SJA; Horsthuis K; Beets-Tan RGH; Marijnen CAM; Tanis PJ; Kusters M;
    Dis Colon Rectum; 2024 Jan; 67(1):42-53. PubMed ID: 37260270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Metastasis as the First Site of Metastasis After Curative Surgery for Colon Cancer: Incidence and Risk Factors According to the TNM Stage.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park Y; Shin JK
    Dis Colon Rectum; 2024 Apr; 67(4):523-530. PubMed ID: 38147433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial.
    Williams H; Thompson HM; Lin ST; Verheij FS; Omer DM; Qin LX; Garcia-Aguilar J;
    Dis Colon Rectum; 2024 Mar; 67(3):369-376. PubMed ID: 38039292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of Mucinous Adenocarcinoma in Stage II and III Colon Cancer.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park Y; Shin JK
    Dis Colon Rectum; 2023 Nov; 66(11):1473-1480. PubMed ID: 37260257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.